INAB
IN8bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.20
+3.45%Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- -0.86x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.13x
- Net debt / EBITDA
- 0.94x
Liquidity & coverage
- Current ratio
- 8.21x
- Quick ratio
- 8.21x
- Cash ratio
- 7.97x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $16.2M
Cash & dividend
- FCF / debt
- -6.71x
- Cash flow / debt
- -6.59x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026